• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLC201400
Device Problems Detachment Of Device Component (1104); Unintended Collision (1429); Difficult to Remove (1528)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/19/2015
Event Type  malfunction  
Event Description
On (b)(6) 2015, the patient underwent treatment of an abdominal aortic aneurysm with gore® excluder® aaa endoprostheses.Reportedly, the contralateral leg component was deployed without issue.It was reported that during withdrawal of the delivery catheter back into the sheath, the device caught on the edge of the sheath, causing the leading olive to completely separate from the graft and remain within the patient.The physician was able to snare the olive for removal from the patient.The procedure was concluded with no further issue, and the patient tolerated the procedure.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Manufacturer Narrative
The catheter was returned for evaluation.The evaluation showed that the leading end of the catheter had separated from the catheter body at the trailing olive.The guidewire lumen had pulled out of the trailing olive bond on the catheter.The findings from the evaluation are consistent with the physician¿s observations.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), do not continue to withdraw the delivery catheter if resistance is felt during removal through the introducer sheath.Forcibly withdrawing the delivery catheter through the introducer sheath when resistance is encountered has resulted in adverse events including catheter separation and reintervention.The catheter separation was due to the polyimide guidewire lumen pulling out of the trailing olive.The root cause for the broken leading end of the catheter could not be determined with the currently available information.
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
nataliya baramzina
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4614184
MDR Text Key5592899
Report Number3007284313-2015-00028
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/14/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2017
Device Catalogue NumberPLC201400
Device Lot Number13301962
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/13/2015
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/12/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age86 YR
Patient Weight75
-
-